Liang H - Search Results

1

Long non‑coding RNA FOXD2‑AS1/miR‑150‑5p/PFN2 axis regulates breast cancer malignancy and tumorigenesis.

Jiang M, Qiu N, Xia H, Liang H, Li H, Ao X. Jiang M, et al. Among authors: liang h. Int J Oncol. 2019 Mar;54(3):1043-1052. doi: 10.3892/ijo.2019.4671. Epub 2019 Jan 3. Int J Oncol. 2019. PMID: 30628646

2

Expression profile of Oct-4 lung cancer-specific marker prior and subsequent to a salirasib treatment regime.

Ao X, Zhou J, Liang HL, Jiang M, Li HS. Ao X, et al. Oncol Lett. 2017 Nov;14(5):5145-5148. doi: 10.3892/ol.2017.6868. Epub 2017 Sep 1. Oncol Lett. 2017. PMID: 29142598 Free PMC article.

3

lincRNA‑p21 inhibits the progression of non‑small cell lung cancer via targeting miR‑17‑5p.

Ao X, Jiang M, Zhou J, Liang H, Xia H, Chen G. Ao X, et al. Among authors: liang h. Oncol Rep. 2019 Feb;41(2):789-800. doi: 10.3892/or.2018.6900. Epub 2018 Nov 30. Oncol Rep. 2019. PMID: 30535441 Free PMC article.

4

Downregulation of miroRNA-141 mediates acquired resistance to trastuzumab and is associated with poor outcome in breast cancer by upregulating the expression of ERBB4.

Han G, Qiu N, Luo K, Liang H, Li H. Han G, et al. Among authors: liang h. J Cell Biochem. 2019 Jul;120(7):11390-11400. doi: 10.1002/jcb.28416. Epub 2019 Feb 11. J Cell Biochem. 2019. PMID: 30746756

5

Cullin7 enhances resistance to trastuzumab therapy in Her2 positive breast cancer via degrading IRS-1 and downregulating IGFBP-3 to activate the PI3K/AKT pathway.

Qiu N, He YF, Zhang SM, Zhan YT, Han GD, Jiang M, He WX, Zhou J, Liang HL, Ao X, Xia HM, Li J, Yang YY, He ZM, Zou ZZ, Li HS. Qiu N, et al. Cancer Lett. 2019 Nov 1;464:25-36. doi: 10.1016/j.canlet.2019.08.008. Epub 2019 Aug 25. Cancer Lett. 2019. PMID: 31461670

6

Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1⁺ CD8⁺ and CD8⁺ T cells as predictive of response to neoadjuvant chemotherapy in breast cancer.

Liang H, Li H, Xie Z, Jin T, Chen Y, Lv Z, Tan X, Li J, Han G, He W, Qiu N, Jiang M, Zhou J, Xia H, Zhan Y, Cui L, Guo W, Huang J, Zhang X, Wu YL. Liang H, et al. Thorac Cancer. 2020 Oct;11(10):2941-2954. doi: 10.1111/1759-7714.13639. Epub 2020 Sep 7. Thorac Cancer. 2020. PMID: 32894006 Free PMC article.

7

TMB and TCR Are Correlated Indicators Predictive of the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer.

Liang H, Huang J, Ao X, Guo W, Chen Y, Lu D, Lv Z, Tan X, He W, Jiang M, Xia H, Zhan Y, Guo W, Ye Z, Jiao L, Ma J, Wang C, Li H, Zhang X, Huang J. Liang H, et al. Front Oncol. 2021 Dec 7;11:740427. doi: 10.3389/fonc.2021.740427. eCollection 2021. Front Oncol. 2021. PMID: 34950580 Free PMC article.

8

Single-cell sequencing reveals the immune landscape of breast cancer patients with brain metastasis.

Zhou H, He X, Huang J, Zhong Y, Zhang L, Ao X, Zhao H, Hu S, Li H, Huang J, Huang H, Liang H. Zhou H, et al. Among authors: liang h. Thorac Cancer. 2024 Mar;15(9):702-714. doi: 10.1111/1759-7714.15243. Epub 2024 Feb 5. Thorac Cancer. 2024. PMID: 38316626 Free PMC article.

9

Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299.

Huang JQ, Liang HL, Zhang XC, Xie Z, Jin TE. Huang JQ, et al. Asia Pac J Clin Oncol. 2016 Mar;12(1):41-51. doi: 10.1111/ajco.12419. Epub 2015 Dec 1. Asia Pac J Clin Oncol. 2016. PMID: 26620316

10

Altered expression profile of apoptosis-related molecules correlated with clinicopathological factors in non-small-cell lung cancer.

Huang JQ, Liang HL, Jin TE, Xie Z. Huang JQ, et al. Int J Clin Exp Pathol. 2015 Sep 1;8(9):11278-86. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26647102 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,964 results

Search Page

Filters